Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 146.12 million compared to CNY 104.08 million a year ago. Revenue was CNY 150.38 million compared to CNY 107.68 million a year ago.

Net income was CNY 1.96 million compared to CNY 0.29352 million a year ago. Basic earnings per share from continuing operations was CNY 0.0065 compared to CNY 0.001 a year ago. Diluted earnings per share from continuing operations was CNY 0.0065 compared to CNY 0.001 a year ago.